Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

In the media
(-) Partner news

Period

2020
2019

Jan
Feb
Apr
(-) May
Jun
Sep
Oct
Nov
Dec

Locations & regions

(-) EMEA

Focus area

Pharmaceuticals

Clear filters

News

Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics

Read full story

TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform

Read full story

Sidebar

Currently trending

Currently trending

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
ViaCyte Appoints Michael Yang President and CEO and Provides Company Update
Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology
£10 million research collaboration to detect lung cancer earlier
4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic
Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Trending

Trending

Collaborating for What’s Now & What’s Next: 1859

Collaborating for What’s Now & What’s Next: Monash University

Collaborating for What’s Now & What’s Next: Koa Health